Guava Technologies has appointed Philip Vorwald as the company’s new vice president of worldwide sales.
Vorwald joins Guava most recently from Delphi Medical Systems, where he served as managing director. Prior to this, he held several senior-level positions at Becton Dickinson Biosciences, including vice president of business operations for Europe/Middle East and Asia/Pacific/Latin America; and in strategic planning in the US, Guava said.
Vorwald holds an MS from the Medical College of Virginia and a BS from the Catholic University in Washington, DC.
Stephen Costalas has been named executive vice president, general counsel, and secretary at Pharmacopeia Drug Discovery, the Princeton, NJ-based company said last week.
Costalas joins PDD from the corporate and securities group of Dechert LLP, where he served as lead outside counsel to Pharmacopeia. He holds a JD from the University of Pennsylvania Law School, and an AB from Dartmouth College.
Terence McGowan has been appointed director of institutional advancement at the Boston Biomedical Research Institute, based in Watertown, Mass.
McGowan joins BBRI from Dana-Farber Cancer Institute, where he was associate director of corporate and foundation relations. He has also held positions at Specialized Health Management, SeniorLink, Brigham & Women’s Hospital, and Charles River Hospital.